Robert J Fox
Robert J Fox
Mellen Center for Multiple Sclerosis, Cleveland Clinic
Bestätigte E-Mail-Adresse bei ccf.org - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Defining the clinical course of multiple sclerosis
FD Lublin, SC Reingold, JA Cohen, GR Cutter, PS Sørensen, ...
Neurology 83 (3), 278-286, 2014
5596*2014
B-cell depletion with rituximab in relapsing–remitting multiple sclerosis
SL Hauser, E Waubant, DL Arnold, T Vollmer, J Antel, RJ Fox, A Bar-Or, ...
New England Journal of Medicine 358 (7), 676-688, 2008
20762008
Defining the clinical course of multiple sclerosis: the 2013 revisions
FD Lublin, SC Reingold, JA Cohen, GR Cutter, PS Sørensen, ...
Neurology 83 (3), 278-286, 2014
17752014
Defining the clinical course of multiple sclerosis: the 2013 revisions
FD Lublin, SC Reingold, JA Cohen, GR Cutter, PS Sørensen, ...
Neurology 83 (3), 278-286, 2014
17752014
Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis
RJ Fox, DH Miller, JT Phillips, M Hutchinson, E Havrdova, M Kita, M Yang, ...
New England Journal of Medicine 367 (12), 1087-1097, 2012
11012012
Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis
RJ Fox, DH Miller, JT Phillips, M Hutchinson, E Havrdova, M Kita, M Yang, ...
New England Journal of Medicine 367 (12), 1087-1097, 2012
11012012
Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis
RJ Fox, DH Miller, JT Phillips, M Hutchinson, E Havrdova, M Kita, M Yang, ...
New England Journal of Medicine 367 (12), 1087-1097, 2012
11012012
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients
R Dutta, J McDonough, X Yin, J Peterson, A Chang, T Torres, T Gudz, ...
Annals of neurology 59 (3), 478-489, 2006
7822006
Treatment of neuromyelitis optica with rituximab
A Jacob, BG Weinshenker, I Violich, N McLinskey, L Krupp, RJ Fox, ...
Arch Neurol 65 (11), 1443-8, 2008
4642008
Rituximab in relapsing‐remitting multiple sclerosis: a 72‐week, open‐label, phase I trial
A Bar‐Or, PAJ Calabresi, D Arnold, C Markowitz, S Shafer, LH Kasper, ...
Annals of neurology 63 (3), 395-400, 2008
4432008
Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic …
LS Brady, HJ Whitfield, RJ Fox, PW Gold, M Herkenham
The Journal of clinical investigation 87 (3), 831-837, 1991
3871991
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ...
The Lancet 391 (10127), 1263-1273, 2018
2862018
Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function
BO Khatri, S Man, G Giovannoni, AP Koo, JC Lee, B Tucky, F Lynn, ...
Neurology 72 (5), 402-409, 2009
2792009
MRI findings in Susac’s syndrome
JO Susac, FR Murtagh, RA Egan, JR Berger, R Bakshi, N Lincoff, ...
Neurology 61 (12), 1783-1787, 2003
2642003
Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients
R Dutta, A Chang, MK Doud, GJ Kidd, MV Ribaudo, EA Young, RJ Fox, ...
Annals of neurology 69 (3), 445-454, 2011
2262011
Multiple sclerosis normal‐appearing white matter: Pathology–imaging correlations
NM Moll, AM Rietsch, S Thomas, AJ Ransohoff, JC Lee, R Fox, A Chang, ...
Annals of neurology 70 (5), 764-773, 2011
2112011
Optimization of cRNA probein situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain: A detailed protocol
HJ Whitfield, LS Brady, MA Smith, E Mamalaki, RJ Fox, M Herkenham
Cellular and molecular neurobiology 10 (1), 145-157, 1990
1961990
Modulating CCR2 and CCL2 at the blood–brain barrier: relevance for multiple sclerosis pathogenesis
D Mahad, MK Callahan, KA Williams, EE Ubogu, P Kivisäkk, B Tucky, ...
Brain 129 (1), 212-223, 2006
1872006
Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives
D Ontaneda, RJ Fox, J Chataway
The Lancet Neurology 14 (2), 208-223, 2015
1822015
Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function
D Ontaneda, AJ Thompson, RJ Fox, JA Cohen
The Lancet 389 (10076), 1357-1366, 2017
1682017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20